Postherpetic neuralgia in immunocompetent elderly people

Vaccine

Volumn 16, Issue 18, 1998, Pages 1768-1770

  Schmader, Kenneth ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CHICKENPOX VACCINE; FAMCICLOVIR; OPIATE AGONIST; VALACICLOVIR;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; HERPES ZOSTER; HUMAN; PATHOGENESIS; POSTHERPETIC NEURALGIA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; VACCINATION; VARICELLA ZOSTER VIRUS;

AGED; AGING; CLINICAL TRIALS; HERPES ZOSTER; HUMANS; MIDDLE AGED; NEURALGIA;

EID: 0032211365     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00137-6     Document Type: Article

References (34)

1. 1 Hope-Simpson, R.E. Postherpetic neuralgia. J. Royal College Gen. Pract. 1975, 25, 571-575.
2. 2 Dworkin, R.H. and Portenoy, R.K. Proposed classification of herpes zoster pain (letter). Lancet 1994, 343, 1648.
3. 3 deMorgas, J.M. and Kierland, R.R. The outcome of patients with herpes zoster. Arch. Derm. 1957, 75, 193-196.
4. 4 Choo, P.W., Galil, K. and Donahue, J.G. et al. ??. Arch. Int. Med. 1997, 157, 1217-1224.
5. 5 Dworkin, R.H. and Portenoy, R.K. Pain and its persistence in herpes zoster. Pain 1996, 67, 241-251.
6. 6 Dworkin, R.H., Hartstein, G. and Rosner, H.L. et al. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J. Abnormal Psychol. 1992, 101, 200-205.
7. 7 Nurmikko, T., Wells, C. and Bowsher, D. Pain and allodynia in postherpetic neuralgia: role of somatic and sympathetic nervous systems. Acta Neurol. Scand. 1991, 84, 146-152.
8. 8 Rogers, R.S. and Tindall, J.P. Geriatric herpes zoster. J. Am. Geriatr. Soc. 1971, 19, 495-504.
9. 9 Watson, C.P.N., Watt, V.R. and Chipman, M. et al. The prognosis with potherpetic neuralgia. Pain 1991, 46, 195-199.
10. 10 Watson, C.P.N., Deck, J.H. and Morshead, C. et al. Postherpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991, 44, 105-117.
11. 11 Head, H. and Campbell, A.W. The pathology of herpes zoster and its bearing on sensory localization. Brain 1900, 23, 353-523.
12. 12 Noordenbos, W. Pain: problems pertaining to the transmission of nerve impulses which gave rise to pain. Elsevier, Amsterdam, 1959, pp. 4-10, 68-80.
13. 13 Bennett, G.J. Hypotheses on the pathogenesis of herpes zoster associated pain. Ann. Neurol. 1994, 35(suppl), S38-S42.
14. 14 Bhala, B.B., Ramamoorthy, C. and Bowsher, D. et al. Shingles and post-herpetic neuralgia. Clin. J. Pain 1988, 4, 169-174.
15. 15 Rowbotham, M.C. and Fields, H.L. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance and skin temperature. Pain 1989, 39, 129-144.
16. 16 Bowsher, D. Sensory change in postherpetic neuralgia. In; Herpes Zoster and Postherpetic Neuralgia (Ed. Watson, C.P.N.). Elsevier, Amsterdam, 1993, pp. 97-106.
17. 17 Nurmikko, T. and Bowsher, D. Somatosensory findings in postherpetic neuralgia. J. Neurol. Neurosurg. Psychiatr. 1990, 53, 135-141.
18. 18 Kost, R.G. and Straus, S.E. Postherpetic neuralgia - pathogenesis, treatment, prevention. N. Engl. J. Med. 1996, 335, 32-42.
19. 19 Watson, C.P.N., Evans, R.J. and Reed, K. et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982, 32, 671-673.
20. 20 Max, M.B., Schafer, S.C. and Culnane, M. et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988, 38, 1427-1432.
21. 21 Kishore-Kumar, R., Max, M.B. and Schafer, S.C. et al. Desipramine relieves postherpetic neuralgia. Clin. Pharm. Therap. 1990, 47, 305-312.
22. 22 Watson, C.P.N., Chipman, M. and Reed, K. et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992, 48, 29-36.
23. 23 Watson, C.P., Tyler, K.L. and Bickers, D.R. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Therapeut. 1993, 15, 510-526.
24. 24 Rowbotham, M.C., Miller, K.V. and Davies, P. et al. Topical lidocaine for post-herpetic neuralgia pain: results of a double blind, vehicle controlled trial. Neurology 1992, 42(suppl)., 390
25. 25 Nathan, P.W. and Wall, P.D. Treatment of post-herpetic neuralgia by prolonged electric stimulation. BMJ 1974, 3, 645-647.
26. 26 Rowbotham, M.C. Managing post-hepertic neuralgia with opioids and local anesthetics. Ann. Neurol. 1993, 35(suppl), S46-S49.
27. 27 Schmader, K.E. and Studenski, S. Are current therpaies useful for the prevention of postherpetic neuralgia? A critical analysis of the literature. J. Gen. Intern. Med. 1989, 4, 83-89.
28. 28 McKendrick, M.W., McGill, J.I. and Wood, M.J. Lack of effect of acyclovir on postherpetic neuralgia. BMJ 1989, 298, 431.
29. 29 Beutner, K.R., Friedman, D.J. and Forszpaniak, C. et al. Valaciclovir compared with acyclovir for improved therapy of herpes zoster in immunocompetent adults. Antimicrobial Agents Chemotherapy 1995, 39, 1546-1553.
30. 30 Tyring, S., Barabarsh, R.A. and Nahlik, J.E. et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann. Int. Med. 1995, 123, 89-96.
31. 31 Wood, M.J., Kay, R. and Dworkin, R.H. et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin. Infect. Dis. 1996, 22, 341-347.
32. 32 Wood, M.J., Johnson, R.W. and McKendrick, M.W. et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med. 1994, 330, 896-900.
33. 33 Esmann, V., Geil, J.P. and Kroon, S. et al. Prednisolone does not prevent postherpetic neuralgia. Lancet 1987, 2, 126-129.
34. 34 Whitley, R.J., Weiss, H. and Gnann, J.W. et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. Ann. Intern. Med. 1996, 125, 376-383.